Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 5/20 | 1.00 |
| ▸ | CA12 | O43570 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA7 | P43166 | 3/20 | 0.48 |
| ▸ | CA9 | Q16790 | 3/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | CA3 | P07451 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | CA6 | P23280 | 2/20 | 0.46 |
| ▸ | CA5A | P35218 | 2/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | SELL | P14151 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | SELP | P16109 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4265743 | 0.97 | TPMT (0.95) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL23817375 | 0.84 | TPMT (0.71) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL14275457 | 0.82 | TPMT (0.67) | TPMTMAPTMAPK1TDP1TSHR | |
| SCHEMBL1613916 | 0.81 | TPMT (0.68) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL16049973 | 0.79 | TPMT (0.65) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL864680 | 0.79 | TPMT (0.65) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL21836922 | 0.79 | TPMT (0.65) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL25610863 | 0.79 | TPMT (0.65) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL670788 | 0.76 | TTR (0.65) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL14264012 | 0.76 | TPMT (0.61) | TPMTCA5ALMNAMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116875024-A | Hydrogel with X-ray visibility and preparation method and application thereof | 赛克赛斯生物科技股份有限公司 | 2023-10-13 | — | — | CN | claimed |
| EP-3631442-A1 | FUNCTIONLIZED CALIBRANTS FOR SPECTROMETRY AND CHROMATOGRAPHY | The Administrators of The Tulane Educational Fund (US) | 2020-04-08 | — | — | EP | claimed |
| WO-2018222593-A1 | FUNCTIONLIZED CALIBRANTS FOR SPECTROMETRY AND CHROMATOGRAPHY | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2018-12-06 | — | — | WO | claimed |
| EP-2066362-A1 | RADIOPAQUE AMIDE POLYMERS AND MEDICAL DEVICES FORMED THEREOF | Boston Scientific Limited (BB) | 2009-06-10 | — | — | EP | claimed |
| WO-2008033198-A1 | RADIOPAQUE AMIDE POLYMERS AND MEDICAL DEVICES FORMED THEREOF | BOSTON SCIENTIFIC LIMITED (BB) | 2008-03-20 | — | — | WO | claimed |
| US-20080064848-A1 | Radiopaque amide polymers and medical devices formed thereof | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-03-13 | — | — | US | claimed |
| EP-0070198-B1 | RADIATION-SENSITIVE COMPOSITION AND PATTERN-FORMATION METHOD USING THE SAME | Hitachi, Ltd. (JP) | 1985-06-19 | — | — | EP | claimed |
| EP-0070198-A1 | Radiation-sensitive composition and pattern-formation method using the same | Hitachi, Ltd. (JP) | 1983-01-19 | — | — | EP | claimed |
| EP-0050457-A1 | Radiopaque cyanoacrylate compositions | BioNexus, Inc. (US) | 1982-04-28 | — | — | EP | claimed |
| CN-122028942-A | Gel for treating fistulae and related methods | 波士顿科学国际有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260049178-A1 | CROSSLINKING AGENTS AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| US-20260041799-A1 | HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-02-12 | — | — | US | disclosed |
| US-20260014282-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES FOR USE IN MEDICAL HYDROGELS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-01-15 | — | — | US | disclosed |
| WO-1990009450-A2 | METHOD FOR INCREASING THE ABILITY OF MAIZE TO UNDERGO ANDROGENESIS, AND PRODUCTS PRODUCED THEREFROM | UNITED AGRISEEDS, INC. (US) | 1990-08-23 | — | — | WO | disclosed |
| EP-0111608-B1 | PSEUDOTROPYL HALOGENO-BENZOATES AND THEIR USE IN MIGRAINE TREATMENT | MERRELL TORAUDE ET COMPAGNIE (FR) | 1987-03-11 | — | — | EP | disclosed |
| EP-0070198-B1 | RADIATION-SENSITIVE COMPOSITION AND PATTERN-FORMATION METHOD USING THE SAME | Hitachi, Ltd. (JP) | 1985-06-19 | — | — | EP | disclosed |
| US-4486441-A | PROPHYLAXIS | MERRELL TORAUDE ET COMPAGNIE (FR) | 1984-12-04 | — | — | US | disclosed |
| US-4465768-A | Pattern-formation method with iodine containing azide and oxygen plasma etching of substrate | HITACHI, LTD. (JP) | 1984-08-14 | — | — | US | disclosed |
| EP-0111608-A1 | Pseudotropyl halogeno-benzoates and their use in migraine treatment | MERRELL TORAUDE ET COMPAGNIE (FR) | 1984-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | KLK3, BRDT, BPHL | TPMT 4080/4885CA12 233/4885CA1 390/4885 |
| US-20260049178-A1 | CROSSLINKING AGENTS AND MEDICAL HYDROGELS FORMED THEREFROM | NPPA, MACF1, IGF1R | TPMT 3130/4885CA12 232/4885CA1 1009/4885 |
| US-20260014282-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES FOR USE IN MEDICAL HYDROGELS | IAPP, NPPA, ARG1 | TPMT 4779/4885CA12 347/4885CA1 226/4885 |
| US-20260041799-A1 | HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME | PAM, CRYAA, COL1A1 | TPMT 3261/4885CA12 1211/4885CA1 844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.